✦ LIBER ✦

Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel

✍ Scribed by Sekine, I.; Ichinose, Y.; Nishiwaki, Y.; Yamamoto, N.; Tsuboi, M.; Nakagawa, K.; Shinkai, T.; Negoro, S.; Imamura, F.; Eguchi, K.; Takeda, K.; Itoh, Y.; Tamura, T.; Saijo, N.; Fukuoka, M.

Book ID: 121729511
Publisher: Oxford University Press
Year: 2009
Tongue: English
Weight: 291 KB
Volume: 20
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdp031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Phase III Trial of Pemetrexed

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy

✍ Hanna, N.; Shepherd, F. A.; Fossella, F. V.; Pereira, J. R.; De Marinis, F.; von 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 229 KB

A Randomized Phase II Study of Gefitinib

A Randomized Phase II Study of Gefitinib Plus Simvastatin Versus Gefitinib Alone in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

✍ Han, J.-Y.; Lee, S.-H.; Yoo, N. J.; Hyung, L. S.; Moon, Y. J.; Yun, T.; Kim, H. 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 317 KB

Molecular Predictors of Outcome With Gef

Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non-Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial

✍ Douillard, J.-Y.; Shepherd, F. A.; Hirsh, V.; Mok, T.; Socinski, M. A.; Gervais, 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 241 KB

Quality of life assessment of second-lin

Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial

✍ Dancey, J 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Docetaxel Versus Docetaxel/Cisplatin in

Docetaxel Versus Docetaxel/Cisplatin in Patients with Advanced Non–Small-Cell Lung Cancer: Preliminary Analysis of a Multicenter, Randomized Phase III Study

✍ V. Georgoulias; A.G. Pallis; C. Kourousis; A. Alexopoulos; A. Ardavanis; A. Agel 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 150 KB

Docetaxel versus supportive care in prev

Docetaxel versus supportive care in previously treated patients with non-small cell lung cancer (NSCLC): Analysis of quality of life and clinical benefit parameters in a randomized trial

✍ Gralla, R.J; Shepherd, F.A; Kim, Y.P; Bizzari, J.P 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 91 KB